Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Investigate FP002 in Subjects With Advanced Malignancies
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- Drug: FP002 Injection
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Guangdong Fapon Biopharma Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT05982080
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
π¨π³Shangdong Cancer Hospital & Institute, Jinan, Shangdong, China
π¨π³Linyi Cancer Hospital, Linyi, Shangdong, China
News
No news found